Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77.6M
-
Number of holders
-
270
-
Total shares
-
68.2M
-
Shares change
-
-4.29M
-
Total reported value, excl. options
-
$2.8B
-
Value change
-
-$206M
-
Put/Call ratio
-
0.09
-
Number of buys
-
129
-
Number of sells
-
-149
-
Price
-
$41.13
Significant Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) as of Q2 2023
274 filings reported holding IART - INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock as of Q2 2023.
INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) has 270 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.2M shares
of 77.6M outstanding shares and own 87.85% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.09M shares), BlackRock Inc. (6.78M shares), MORGAN STANLEY (6.26M shares), Champlain Investment Partners, LLC (3.9M shares), WELLINGTON MANAGEMENT GROUP LLP (3.36M shares), Capital Research Global Investors (3.26M shares), ALLIANCEBERNSTEIN L.P. (2.88M shares), Clearbridge Investments, LLC (2.76M shares), COOKE & BIELER LP (2.74M shares), and STATE STREET CORP (2.22M shares).
This table shows the top 270 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.